H. Lundbeck A/S Newsletter
-
Assessing Eptinezumab’s Impact in Reducing Migraine Burden Through Longer Interictal Periods: Amaal Starling, MD, FAHS, FAAN
11 Jul 2025 12:30 GMT
… study of eptinezumab (Vyepti; Lundbeck), an FDA-approved preventive … 2025.
REFERENCES
1. Lundbeck Advances Leadership in Migraine … Scientific Meeting. News Release. Lundbeck. Published June 19, 2025. … /2025/lundbeck-advances-leadership-in-migraine-with …
-
Doubt Cast on the Need for Long-Term Antidepressant Tapering
11 Jul 2025 07:55 GMT
… , the Dubai Masterclass conference, Janssen, Lundbeck, and Recordati; serving as a … of the Neurotorium editorial board, Lundbeck Foundation. Vinkers reported being involved …
-
The First Pandemic? Scientists Find 214 Ancient Pathogens in Prehistoric DNA
11 Jul 2025 11:22 GMT
… possible by funding from the Lundbeck Foundation.
-
Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight
11 Jul 2025 00:14 GMT
… SANKYO COMPANY, LIMITED, AbbVie Inc., Lundbeck, Biogen, Cipla, among others.
Alzheimer …
-
Cannabis Cuts Migraine in First Placebo-Controlled Trial
10 Jul 2025 20:55 GMT
… on the advisory boards of Lundbeck and Rapport; and held stock …
-
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
10 Jul 2025 17:00 GMT
… , Integrative Research Laboratories AB, H. Lundbeck A/S, Shanghai WD … Pharmaceuticals Inc., Otsuka America Pharmaceutical, Lundbeck LLC, Jazz Pharmaceuticals, Alkahest Inc …
-
Europe Pharmaceutical Drugs Market Expands with R&D Innovation, Biologics Growth, and Regulatory Harmonization 2025–2032
10 Jul 2025 08:24 GMT
… S.A.
» UCB S.A.
» Lundbeck A/S
» Grünenthal GmbH …
-
Largest study of ancient DNA traces infectious diseases through history
10 Jul 2025 01:29 GMT
… possible by funding from the Lundbeck Foundation.
Source:
Journal reference:
Sikora …
-
Children, adolescents see fewer migraine days with fremanezumab
09 Jul 2025 18:14 GMT
… , Depomed, HEAL, Impax, Eli Lilly, Lundbeck, NIH Common Data Elements, and …
-
Iambic and Revolution Medicines Partner on AI Cancer Drug Discovery
09 Jul 2025 16:12 GMT
… , Iambic announced a partnership with Lundbeck, a pharmaceutical company focused on …